Pharma Journalist - Page 879 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Opsis Therapeutics announces SAB for advancement in retinal cell therapies

Lamellar Biomedical Raises funding of £5.75 Million

Crown Bioscience collaborates with Jiangsu Qyun Bio-Pharmaceutical to develop antibody

GenSight appoints Mohamed Genead as CMO

AstraZeneca enters a $2.1 billion collaboration with Pieris for drug research

Epizyme Earns $10 Million from GSK for GLP Toxicology studies

Corvus Pharmaceutical Expands its Collaboration with Genentech

Provista appoints Jim Cunniff as new president and CEO

Quivive Pharma and Camargo Pharmaceutical Services join hands for Development Programs

SGS announces completion of Phase I flu trials in healthy Volunteers